Search - tctmd.com

Displaying 61 - 80 of 168

Sort: Relevancy | Date

Presentation

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Presenter: Akshay Bagai

August 12, 2014

Presentation

Variability of Individual Platelet Reactivity Over Time in Patients Treated with Clopidogrel

Presenter: W. Hochholzer

July 21, 2014

Presentation

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Presenter: J.A. Udell

June 17, 2014

Presentation

Clopidogrel Prescription Filling Delays and Cardiovascular Outcomes in a Pharmacy System Integrating Inpatient and Outpatient Care

Presenter: J.B. Byrd

June 16, 2014

Presentation

Delay in Filling First Clopidogrel Prescription after Coronary Stenting Is Associated with an Increased Risk of Death and MI

Presenter: Nicholas L. Cruden

May 28, 2014

Presentation

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Presenter: Stefanie Schulz

May 14, 2014

Presentation

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Presenter: D. Lindholm

April 25, 2014

Presentation

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Presenter: J.P. Loh

April 11, 2014

Presentation

Incidence and Impact of Stent Thrombosis after PCI: Comparison of Cangrelor and Clopidogrel

Presenter: Philippe Généreux

April 02, 2014

Presentation ACC 2014

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Presenter: Philippe Généreux

March 30, 2014

Presentation

Risk of Stroke in Patients with High On-Clopidogrel Platelet Reactivity to Adenosine Diphosphate after PCI

Presenter: Nevio Taglieri

March 25, 2014

Presentation

INFUSE-AMI: Outcomes in Patients with STEMI Treated with Clopidogrel vs Prasugrel

Presenter: Sorin J. Brener

February 26, 2014

Presentation

Loading Dose Has No Additive Effect on Platelet Aggregation During the Switch from Ongoing Clopidogrel to Ticagrelor in ACS Patients

Presenter: G. Caiazzo

January 28, 2014

Presentation

A Randomised Controlled Trial of Platelet Activity Before and After Cessation of Clopidogrel in Patients with Stable Cardiovascular Disease

Presenter: Isobel Ford

November 12, 2013

Presentation TCT 2013

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Presenter: Freek Verheugt

October 31, 2013

Presentation TCT 2013

No, Clopidogrel Is Safer and Effective Enough for Many Patients!

Presenter: Jorge Saucedo

October 31, 2013

Presentation TCT 2013

Clopidogrel Is Cheap, Effective, and Sufficient for Most!

Presenter: Fausto Feres

October 31, 2013

Presentation TCT 2013

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

Presenter: Michel Le May

October 30, 2013

Presentation TCT 2013

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

Presenter: Joshua Loh

October 29, 2013

Presentation TCT 2013

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

Presenter: Keith Oldroyd

October 29, 2013

Advertisement

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Variability of Individual Platelet Reactivity Over Time in Patients Treated with Clopidogrel

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Clopidogrel Prescription Filling Delays and Cardiovascular Outcomes in a Pharmacy System Integrating Inpatient and Outpatient Care

Delay in Filling First Clopidogrel Prescription after Coronary Stenting Is Associated with an Increased Risk of Death and MI

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Incidence and Impact of Stent Thrombosis after PCI: Comparison of Cangrelor and Clopidogrel

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Risk of Stroke in Patients with High On-Clopidogrel Platelet Reactivity to Adenosine Diphosphate after PCI

INFUSE-AMI: Outcomes in Patients with STEMI Treated with Clopidogrel vs Prasugrel

Loading Dose Has No Additive Effect on Platelet Aggregation During the Switch from Ongoing Clopidogrel to Ticagrelor in ACS Patients

A Randomised Controlled Trial of Platelet Activity Before and After Cessation of Clopidogrel in Patients with Stable Cardiovascular Disease

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

No, Clopidogrel Is Safer and Effective Enough for Many Patients!

Clopidogrel Is Cheap, Effective, and Sufficient for Most!

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting...

TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content